A select group of patients with early-stage breast cancer were able to skip surgery without tumor progression after three years, according to results of a Phase 2 trial of ablative radiation therapy and endocrine therapy led by researchers at the University of Texas MD Anderson Cancer Center.
Please follow and like us:
